A 40 minute daily Yoga routine, incorporating select asanas and pranayama, along with standard lifestyle interventions, can reduce the risk of developing diabetes by approximately 40%
This acquisition positions Suven as a key player in one of the fastest growing segments of the Pharma CDMO landscape
The new facility significantly increases Siegfried’s R&D capacity to drive development excellence and further growth
Modernization and supply chain diversity drive new growth
Net profit for the quarter grew by 254.2 per cent and stood at Rs. 20.9 crore
For Q2, Akums reported a consolidated total income of Rs. 1,046.6 crore
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Extension of long-term collaboration includes construction of new customer-dedicated bioconjugation capacity in Visp (CH) and commercial antibody supply of a new ADC
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
The new facility uses the latest mammalian systems and single-use technology, including a production line with eight 2,000 L bioreactors
Subscribe To Our Newsletter & Stay Updated
